This article was originally published in The Rose Sheet
The European Center for the Validation of Alternative Methods will hold a training course Nov. 28-30 on validated in vitro alternatives to topical toxicity testing. The training will focus on the in vitro skin irritation test, the in vitro 3T3 NRU phototoxicity test and the HET-CAM test. The course - to be held in conjunction with the Institute of Pharmacy at the Freie Universität Berlin and the German Federal Institute for Risk Assessment - will take place in Berlin at the Institute of Pharmacy. Representatives from industry, government and academia are invited...
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.